Rating History for AMAG Pharmaceuticals (AMAG) by Piper Sandler

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/1/2020 Christopher J. Raymond Upgrade Neutral
(Underweight)
13.75
(8.00)
9.40
(13.75)
46.28% Details